Allergic rhinitis: therapeutic strategies update Lactococcus lactis Plasma and tranilast-roxithromycin combination
* At present, there is no established definitive and reliable therapy for allergic rhinitis. * Combined effects of tranilast, which inhibits mast cell degranulation, and a specific macrolide antibiotic, roxithromycin, which has T helper 2 (Th2) cell inhibitory effects through ligands and receptors,...
Gespeichert in:
| Veröffentlicht in: | Allergologia et immunopathologia 2024-01, Vol.52 (2), p.1-2 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2 |
|---|---|
| container_issue | 2 |
| container_start_page | 1 |
| container_title | Allergologia et immunopathologia |
| container_volume | 52 |
| creator | Horiuchi, Yasuhiro |
| description | * At present, there is no established definitive and reliable therapy for allergic rhinitis.
* Combined effects of tranilast, which inhibits mast cell degranulation, and a specific macrolide antibiotic, roxithromycin, which has T helper 2 (Th2) cell inhibitory effects through ligands and receptors, may aid significantly in managing allergic rhinitis.
* Lactococcus lactis strain Plasma (LC-Plasma) can induce plasmacytoid dendritic cells and consistent intake of LC-Plasma increases T helper 1 (Th1) responses, indicating a potential to suppress Th2 hypersensitivity conditions, such as allergic rhinitis.
* A novel treatment approach for hay fever can now be chosen based on to the severity of the disease and amount of scattered pollen. |
| doi_str_mv | 10.15586/aei.v52i2.1010 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2954775923</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2954775923</sourcerecordid><originalsourceid>FETCH-LOGICAL-c279t-2497cd6eb39ab071df503e999282a5b8cf5af92af39148dfcfe0c5d16ef602dd3</originalsourceid><addsrcrecordid>eNpdkbtPwzAQxi0EoqUwsyFLLCwpfsSJzVYhXlIlGGCOHD-oqyQutoPgv8eUwsB0351-9-l0HwCnGM0xY7y6lMbN3xlxZI4RRntgilnNC0yqeh9MEUW4QKysJuAoxjVCBJGKHoIJ5SUTnNMpCIuuM-HVKRhWbnDJxSuYVibIjRlTnsYUZDKvzkQ4bnSWcClV8sorNUbYZe0ifOpk7CWUg4YZH1xuUxH8h0ur4PtP5QaofN-6QSbnh2NwYGUXzcmuzsDL7c3z9X2xfLx7uF4sC0VqkQpSilrpyrRUyBbVWFuGqBFCEE4ka7myTFpBpKUCl1xbZQ1STOPK2AoRrekMXPz4boJ_G01MTe-iMl0nB-PH2BDByrpmgtCMnv9D134MQ77um6oFZyUuM3X5Q6ngYwzGNpvgehk-G4yabRxNjqPZxtF8x5E3zna-Y9sb_cf__p9-AQsBicc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2957985414</pqid></control><display><type>article</type><title>Allergic rhinitis: therapeutic strategies update Lactococcus lactis Plasma and tranilast-roxithromycin combination</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Horiuchi, Yasuhiro</creator><creatorcontrib>Horiuchi, Yasuhiro</creatorcontrib><description>* At present, there is no established definitive and reliable therapy for allergic rhinitis.
* Combined effects of tranilast, which inhibits mast cell degranulation, and a specific macrolide antibiotic, roxithromycin, which has T helper 2 (Th2) cell inhibitory effects through ligands and receptors, may aid significantly in managing allergic rhinitis.
* Lactococcus lactis strain Plasma (LC-Plasma) can induce plasmacytoid dendritic cells and consistent intake of LC-Plasma increases T helper 1 (Th1) responses, indicating a potential to suppress Th2 hypersensitivity conditions, such as allergic rhinitis.
* A novel treatment approach for hay fever can now be chosen based on to the severity of the disease and amount of scattered pollen.</description><identifier>ISSN: 0301-0546</identifier><identifier>EISSN: 1578-1267</identifier><identifier>EISSN: 0301-0546</identifier><identifier>DOI: 10.15586/aei.v52i2.1010</identifier><identifier>PMID: 38459883</identifier><language>eng</language><publisher>Singapore: Codon Publications</publisher><subject>Allergies ; Antigens ; Conflicts of interest ; Dendritic cells ; Dermatitis ; Drugs ; Erythema ; Hay fever ; Humans ; Lactococcus lactis ; ortho-Aminobenzoates - therapeutic use ; Patients ; Plasma ; Probiotics ; Rhinitis ; Rhinitis, Allergic - drug therapy ; Roxithromycin - therapeutic use</subject><ispartof>Allergologia et immunopathologia, 2024-01, Vol.52 (2), p.1-2</ispartof><rights>2024. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38459883$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horiuchi, Yasuhiro</creatorcontrib><title>Allergic rhinitis: therapeutic strategies update Lactococcus lactis Plasma and tranilast-roxithromycin combination</title><title>Allergologia et immunopathologia</title><addtitle>Allergol Immunopathol (Madr)</addtitle><description>* At present, there is no established definitive and reliable therapy for allergic rhinitis.
* Combined effects of tranilast, which inhibits mast cell degranulation, and a specific macrolide antibiotic, roxithromycin, which has T helper 2 (Th2) cell inhibitory effects through ligands and receptors, may aid significantly in managing allergic rhinitis.
* Lactococcus lactis strain Plasma (LC-Plasma) can induce plasmacytoid dendritic cells and consistent intake of LC-Plasma increases T helper 1 (Th1) responses, indicating a potential to suppress Th2 hypersensitivity conditions, such as allergic rhinitis.
* A novel treatment approach for hay fever can now be chosen based on to the severity of the disease and amount of scattered pollen.</description><subject>Allergies</subject><subject>Antigens</subject><subject>Conflicts of interest</subject><subject>Dendritic cells</subject><subject>Dermatitis</subject><subject>Drugs</subject><subject>Erythema</subject><subject>Hay fever</subject><subject>Humans</subject><subject>Lactococcus lactis</subject><subject>ortho-Aminobenzoates - therapeutic use</subject><subject>Patients</subject><subject>Plasma</subject><subject>Probiotics</subject><subject>Rhinitis</subject><subject>Rhinitis, Allergic - drug therapy</subject><subject>Roxithromycin - therapeutic use</subject><issn>0301-0546</issn><issn>1578-1267</issn><issn>0301-0546</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkbtPwzAQxi0EoqUwsyFLLCwpfsSJzVYhXlIlGGCOHD-oqyQutoPgv8eUwsB0351-9-l0HwCnGM0xY7y6lMbN3xlxZI4RRntgilnNC0yqeh9MEUW4QKysJuAoxjVCBJGKHoIJ5SUTnNMpCIuuM-HVKRhWbnDJxSuYVibIjRlTnsYUZDKvzkQ4bnSWcClV8sorNUbYZe0ifOpk7CWUg4YZH1xuUxH8h0ur4PtP5QaofN-6QSbnh2NwYGUXzcmuzsDL7c3z9X2xfLx7uF4sC0VqkQpSilrpyrRUyBbVWFuGqBFCEE4ka7myTFpBpKUCl1xbZQ1STOPK2AoRrekMXPz4boJ_G01MTe-iMl0nB-PH2BDByrpmgtCMnv9D134MQ77um6oFZyUuM3X5Q6ngYwzGNpvgehk-G4yabRxNjqPZxtF8x5E3zna-Y9sb_cf__p9-AQsBicc</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Horiuchi, Yasuhiro</creator><general>Codon Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20240101</creationdate><title>Allergic rhinitis: therapeutic strategies update Lactococcus lactis Plasma and tranilast-roxithromycin combination</title><author>Horiuchi, Yasuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c279t-2497cd6eb39ab071df503e999282a5b8cf5af92af39148dfcfe0c5d16ef602dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Allergies</topic><topic>Antigens</topic><topic>Conflicts of interest</topic><topic>Dendritic cells</topic><topic>Dermatitis</topic><topic>Drugs</topic><topic>Erythema</topic><topic>Hay fever</topic><topic>Humans</topic><topic>Lactococcus lactis</topic><topic>ortho-Aminobenzoates - therapeutic use</topic><topic>Patients</topic><topic>Plasma</topic><topic>Probiotics</topic><topic>Rhinitis</topic><topic>Rhinitis, Allergic - drug therapy</topic><topic>Roxithromycin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horiuchi, Yasuhiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Allergologia et immunopathologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horiuchi, Yasuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Allergic rhinitis: therapeutic strategies update Lactococcus lactis Plasma and tranilast-roxithromycin combination</atitle><jtitle>Allergologia et immunopathologia</jtitle><addtitle>Allergol Immunopathol (Madr)</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>52</volume><issue>2</issue><spage>1</spage><epage>2</epage><pages>1-2</pages><issn>0301-0546</issn><eissn>1578-1267</eissn><eissn>0301-0546</eissn><abstract>* At present, there is no established definitive and reliable therapy for allergic rhinitis.
* Combined effects of tranilast, which inhibits mast cell degranulation, and a specific macrolide antibiotic, roxithromycin, which has T helper 2 (Th2) cell inhibitory effects through ligands and receptors, may aid significantly in managing allergic rhinitis.
* Lactococcus lactis strain Plasma (LC-Plasma) can induce plasmacytoid dendritic cells and consistent intake of LC-Plasma increases T helper 1 (Th1) responses, indicating a potential to suppress Th2 hypersensitivity conditions, such as allergic rhinitis.
* A novel treatment approach for hay fever can now be chosen based on to the severity of the disease and amount of scattered pollen.</abstract><cop>Singapore</cop><pub>Codon Publications</pub><pmid>38459883</pmid><doi>10.15586/aei.v52i2.1010</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0301-0546 |
| ispartof | Allergologia et immunopathologia, 2024-01, Vol.52 (2), p.1-2 |
| issn | 0301-0546 1578-1267 0301-0546 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2954775923 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Allergies Antigens Conflicts of interest Dendritic cells Dermatitis Drugs Erythema Hay fever Humans Lactococcus lactis ortho-Aminobenzoates - therapeutic use Patients Plasma Probiotics Rhinitis Rhinitis, Allergic - drug therapy Roxithromycin - therapeutic use |
| title | Allergic rhinitis: therapeutic strategies update Lactococcus lactis Plasma and tranilast-roxithromycin combination |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T17%3A13%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Allergic%20rhinitis:%20therapeutic%20strategies%20update%20Lactococcus%20lactis%20Plasma%20and%20tranilast-roxithromycin%20combination&rft.jtitle=Allergologia%20et%20immunopathologia&rft.au=Horiuchi,%20Yasuhiro&rft.date=2024-01-01&rft.volume=52&rft.issue=2&rft.spage=1&rft.epage=2&rft.pages=1-2&rft.issn=0301-0546&rft.eissn=1578-1267&rft_id=info:doi/10.15586/aei.v52i2.1010&rft_dat=%3Cproquest_cross%3E2954775923%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2957985414&rft_id=info:pmid/38459883&rfr_iscdi=true |